Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol

Abstract Background Women infected with HIV have a risk of preterm birth (PTB) that is twice that among uninfected women, and treatment with antiretroviral therapy (ART) may further increase this risk. Progesterone supplementation reduces the risk of preterm delivery in women who have a shortened ce...

Full description

Bibliographic Details
Main Authors: Joan T. Price, Katie R. Mollan, Nurain M. Fuseini, Bethany L. Freeman, Helen B. Mulenga, Amanda H. Corbett, Bellington Vwalika, Jeffrey S. A. Stringer
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Pilot and Feasibility Studies
Subjects:
Preterm birth
Progesterone
HIV
Antiretroviral therapy
Sub-Saharan Africa
Online Access:http://link.springer.com/article/10.1186/s40814-017-0170-7

Internet

http://link.springer.com/article/10.1186/s40814-017-0170-7

Similar Items